Levobupivacaína Altan

Levobupivacaine, the active ingredient in Levobupivacaína Altan, is a local anesthetic presented as a sterile solution for epidural use. It provides regional anesthesia for surgical procedures, postoperative pain management, and labor analgesia in adult patients. Its stereoselective formulation offers a favorable safety profile compared with racemic bupivacaine, allowing effective nerve block with reduced cardiotoxicity.

GNH USA supplies Levobupivacaína Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levobupivacaine is employed in epidural anesthesia to manage pain associated with surgery, postoperative recovery, and childbirth.

- Surgical procedures: provides epidural anesthesia for intra‑operative pain control. - Postoperative pain management: maintains analgesia after surgery to facilitate recovery. - Labor analgesia: offers effective pain relief during childbirth while preserving maternal consciousness.

Levobupivacaine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hypotension: decreased blood pressure following epidural block. - Bradycardia: slower than normal heart rate. - Motor block: temporary weakness in the lower limbs. - Nausea: feeling of sickness or urge to vomit.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm that can be life‑threatening. - Seizures: uncontrolled electrical activity in the brain. - Respiratory depression: reduced breathing effort requiring support. - Allergic reaction: rash, itching, swelling, or anaphylaxis.

When using Levobupivacaína Altan, clinicians should observe several safety measures to minimize risk.

- Patient assessment: evaluate cardiovascular and neurological status before administration. - Dose titration: adjust concentration based on patient response and procedure length. - Monitoring: continuously observe blood pressure, heart rate, and level of block. - Contraindications: avoid in patients with known hypersensitivity to amide local anesthetics. - Co‑administration with anticoagulants: assess bleeding risk and consider spinal hematoma. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levobupivacaine can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Concurrent use with other local anesthetics: risk of cumulative systemic toxicity. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma concentrations. - Beta‑blockers or calcium channel blockers: can exacerbate bradycardia and hypotension.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may enhance hypotensive effects. - Anticoagulants (e.g., heparin, warfarin): increase risk of spinal or epidural hematoma. - Central nervous system depressants (e.g., opioids, benzodiazepines): may deepen sedation and respiratory depression.